Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis

Clinical Infectious Diseases

Volumn 26, Issue 4, 1998, Pages 903-908

  Arikan, Sevtap ^c   Akova, Murat ^b   Hayran, Murat ^a   Özdemir, Oktay ^a   Erman, Mustafa ^c   Gür, Deniz ^b   Ünal, Serhat ^c  

^a IDE Contract Research Organization   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Section of Infectious Diseases ^*

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA TROPICALIS; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG SENSITIVITY; FEMALE; HUMAN; IN VITRO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; OROPHARYNX; PRIORITY JOURNAL; TORULOPSIS GLABRATA; TREATMENT OUTCOME;

EID: 0031894897     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/513927     Document Type: Article

References (16)

1. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1997.
2. Eldere JV, Joosten L, Verhaeghe A, Surmont I. Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test. J Clin Microbiol 1996;34:842-7.
3. Espinel-Ingroff A, Kish CW Jr, Kerkering TM. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 1992;30:3138-45.
4. Tiballi RN, He X, Zarins LT, Revankar SG, Kauffman CA. Use of a colorimetric system for yeast susceptibility testing. J Clin Microbiol 1995;33:915-7.
5. Rex JH, Pfaller MA, Barry AL, Nelson PW, Webb CD. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob Agents Chemother 1995;39:40-4.
6. Ghannoum M, Rex JH, Galgiani JN. Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J Clin Microbiol 1996;34:489-95.
7. Rex JH, Pfaller MA, Galgiani JN, et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fiuconazole, itraconazole, and candida infections. Clin Infect Dis 1997;24:235-47.
8. Roberts GD. Laboratory methods in basic mycology. In: Baron EJ, Finegold SM, eds. Bailey and Scott's diagnostic microbiology. 8th ed. St. Louis: CV Mosby, 1990;681-775.
9. Ankan S, Gür D, Akova M. Comparison of Etest, microdilution and colorimetric microdilution with reference broth macrodilution method for susceptibility testing of clinically significant Candida species isolated from immunocompromised patients. Mycoses 1997; 7/8 (in press).
10. Akova M, Akalin HE, Uzun Ö, et al. Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing outcome. Clin Infect Dis 1994;18: 298-304.
11. Wingard JR. Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy. Clin Infect Dis 1994; 19 (suppl l):S49-53.
12. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species of fluconazole. Antimicrob Agents Chemother 1995;39:1-8.
13. Akova M, Akalin HE, Uzun Ö, Gür D. Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole. Eur J Clin Microbiol Infect Dis 1991;10:598-9.
14. Boken DJ, Swindells S, Rinaldi MG. Fluconazole-resistant Candida albicans. Clin Infect Dis 1993;17:1018-21.
15. Akova M, Hayran M, Ankan S, Gür D, Ünal S, Akalin HE. Correlation of clinical outcome of candida infections with in vitro antifungal susceptibility testing in patients with severe underlying diseases [abstract no 795]. In: Program and abstracts of the 7th European Congress on Clinical Microbiology and Infectious Diseases. Vienna: European Society of Clinical Microbiology and Infectious Diseases, 1995:155.
16. Steele-Moore L, Schneider B, Berg D, Holloway W. Clinical and in vitro evaluation of 20 AIDS patients with oropharyngeal candidiasis during prolonged antifungal therapy [abstract no 187]. In: Program and abstracts of the 9th International Symposium on Infections in the Immunocompromised Host. Assisi, Italy: The Immunocompromised Host Society, 1996.